ÇIMSA ÇIMENTO SANAYI VE TICARET ANONIM SIRKETI – Trademark Portfolio
Entity Type: 09
ÇIMSA ÇIMENTO SANAYI VE TICARET ANONIM SIRKETI holds 21 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 19 (Building Materials) — 21 filings in this category. Currently, 10 trademarks are registered. Notable registered marks include ÇIMSA CARES, ÇIMSA AMERICAS, ÇIMSA CRAFTA-N, ÇIMSA CRAFTA-S, and ÇIMSA FLYCRETE.
Küçükbakkalköy Mah. Kayisdagi Cad. 1 90
Atasehir Istanbul
Showing of trademarks Trademarks
Trademark Classifications
ÇIMSA ÇIMENTO SANAYI VE TICARET ANONIM SIRKETI's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Building materials (non-metallic); non-metallic rigid pipes for building
Frequently Asked Questions
How many trademarks does ÇIMSA ÇIMENTO SANAYI VE TICARET ANONIM SIRKETI have?
ÇIMSA ÇIMENTO SANAYI VE TICARET ANONIM SIRKETI has 21 U.S. trademarks filed with the USPTO. Of these, 10 registered, 1 abandoned, 6 cancelled.
What trademark classes does ÇIMSA ÇIMENTO SANAYI VE TICARET ANONIM SIRKETI file in?
ÇIMSA ÇIMENTO SANAYI VE TICARET ANONIM SIRKETI files trademarks across 1 Nice Classification class. The most active classes are Class 19 (Building Materials). Class 19 covers building materials (non-metallic); non-metallic rigid pipes for building.
What are ÇIMSA ÇIMENTO SANAYI VE TICARET ANONIM SIRKETI's most well-known trademarks?
ÇIMSA ÇIMENTO SANAYI VE TICARET ANONIM SIRKETI's registered trademark portfolio includes well-known marks such as ÇIMSA CARES, ÇIMSA AMERICAS, ÇIMSA CRAFTA-N, ÇIMSA CRAFTA-S, and ÇIMSA FLYCRETE. These are among 10 currently registered trademarks in the portfolio.
What is ÇIMSA ÇIMENTO SANAYI VE TICARET ANONIM SIRKETI's trademark registration success rate?
ÇIMSA ÇIMENTO SANAYI VE TICARET ANONIM SIRKETI has a 59% trademark registration rate, with 10 out of 17 resolved applications resulting in successful registration. Currently, 0 applications are pending review.